Viewing Study NCT01023035

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:29 PM

Ignite Modification Date: 2026-01-04 @ 4:25 AM

Study NCT ID: NCT01023035

Status: COMPLETED

Last Update Posted: 2021-02-08

First Post: 2009-11-24

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)

Sponsor: Merck Sharp & Dohme LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module